期刊文献+
共找到25篇文章
< 1 2 >
每页显示 20 50 100
High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer
1
作者 Shan Yang Tian-Li Hui +6 位作者 Hao-Qi Wang Xi Zhang Yun-Zhe Mi Meng Cheng Wei Gao Cui-Zhi Geng Sai-Nan Li 《World Journal of Clinical Cases》 SCIE 2023年第20期4788-4799,共12页
BACKGROUND Breast cancer(BC) remains a public health problem. Tamoxifen(TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1(EIF4EBP... BACKGROUND Breast cancer(BC) remains a public health problem. Tamoxifen(TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1(EIF4EBP1) plays critical roles in the tumorigenesis and progression of BC. However, the expression and mechanism of EIF4EBP1 in determining the efficacy of TAM therapy in BC patients are still unclear.AIM To investigate the expression and functions of EIF4EBP1 in determining the efficacy of TAM therapy in BC patients.METHODS High-throughput sequencing data of breast tumors were downloaded from the Gene Expression Omnibus database. Differential gene expression analysis identified EIF4EBP1 to be significantly upregulated in cancer tissues. Its prognostic value was analyzed. The biological function and related pathways of EIF4EBP1 was analyzed. Subsequently, the expression of EIF4EBP1 was determined by real-time reverse transcription polymerase chain reaction and western blotting. Cell Counting Kit-8 assays, colony formation assay and wound healing assay were used to understand the phenotypes of function of EIF4EBP1.RESULTS EIF4EBP1 was upregulated in the TAM-resistant cells, and EIF4EBP1 was related to the prognosis of BC patients. Gene Set Enrichment Analysis showed that EIF4EBP1 might be involved in Hedgehog signaling pathways. Decreasing the expression of EIF4EBP1 could reverse TAM resistance, whereas overexpression of EIF4EBP1 promoted TAM resistance.CONCLUSION This study indicated that EIF4EBP1 was overexpressed in the BC and TAM-resistant cell line, which increased cell proliferation, invasion, migration and TAM resistance in BC cells. 展开更多
关键词 Breast cancer Eukaryotic translation initiation factor 4E binding protein 1 tamoxifen Resistance Prognosis BIOINFORMATICS
下载PDF
Synthesis and antibacterial activity of brominated 2′(4′)-nitro-3-hydroxy diphenyl ethers 被引量:1
2
作者 Xue Tang Min Xie +3 位作者 Yong Xue Sun Jian Hua Li Zhi Cheng Zhong Yu Liang Wang 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第4期435-438,共4页
Eight new brominated 2'(4')-nitro-3-hydroxy diphenyl ethers have been designed and synthesized. The structures of new compounds were confirmed by ^1H NMR, IR and HRMS. The bioactivity tests showed that these compo... Eight new brominated 2'(4')-nitro-3-hydroxy diphenyl ethers have been designed and synthesized. The structures of new compounds were confirmed by ^1H NMR, IR and HRMS. The bioactivity tests showed that these compounds possessed antibacterial activities against the tested bacteria. These new compounds cannot be transformed into dioxins when they were manufactured and used. 展开更多
关键词 Brominated 2'(4')-nitro-3-hydroxy diphenyl ether SYNTHESIS Antibacterial activity
下载PDF
SO<sub>4</sub><sup>2-</sup>/SnO<sub>2</sub>-Catalyzed C3-alkylation of 4-hydroxycoumarin with secondary benzyl alcohols and <i>O</i>-alkylation with <i>O</i>-acetyl compounds 被引量:2
3
作者 Venugopalarao Narayana Ravi Varala Pudukulathan Zubaidha 《International Journal of Organic Chemistry》 2012年第3期287-294,共8页
Sulfated tin oxide (STO) has been found to be an efficient reusable solid superacid catalyst for C3-alkylation and O-alkylation of 4-hydroxycoumarins with benzylic, allylic alcohols/and corresponding acetates respecti... Sulfated tin oxide (STO) has been found to be an efficient reusable solid superacid catalyst for C3-alkylation and O-alkylation of 4-hydroxycoumarins with benzylic, allylic alcohols/and corresponding acetates respectively, in acetic acid under reflux conditions with good yield of products. 展开更多
关键词 C-C and C-O bond formations Sulfated tin oxide (STO) reusability 4-hydroxy coumarin SECONDARY BENZYL alcohol SECONDARY BENZYL O-acetate
下载PDF
Detection of NO_2 Based on 4-Carboxyl-4′-hydroxy Azobenzene and Its Cu(II) Complex
4
作者 李建 龚云 +1 位作者 秦建波 林建华 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2013年第2期252-260,共9页
An organic ligand and its Cu(II) complex formulated as (C13HloN203)·5H2O (H2L·5H2O, 1) and Cu(HL)2(phen)·0.125H2O (2, H2L = 4-carboxyl-4′-hydroxy azobenzene, phen = 1,10-phenanthroline) hav... An organic ligand and its Cu(II) complex formulated as (C13HloN203)·5H2O (H2L·5H2O, 1) and Cu(HL)2(phen)·0.125H2O (2, H2L = 4-carboxyl-4′-hydroxy azobenzene, phen = 1,10-phenanthroline) have been synthesized and structurally characterized by single-crystal X-ray diffraction. In the two compounds, H2L and HL exhibit a trans-conformation. Complex 2 shows a mononuclear Cu(Ⅱ) structure with the hydroxyl group of HL uncoordinated. Complex 2 is assembled into a three-dimensional (3D) supramolecular architecture by hydrogen bonds and π-π stacking interactions. H2L and compound 2 can detect NO2 via reversible and irreversible color changes, respectively. The mechanism for the color changes is investigated. 展开更多
关键词 4-carboxyl-4-hydroxy azobenzene COMPLEX SYNTHESIS structure color change
下载PDF
Synthesis and activities of new 4-hydroxybenzoxazolone derivatives
5
作者 Tang, Li Ban, Shu Rong +2 位作者 Feng, Xiu E. Lin, Wen Han Li, Qing Shan 《Chinese Chemical Letters》 SCIE CAS CSCD 2010年第1期63-66,共4页
关键词 SYNTHESIS 4-hydroxy benzoxazolone derivatives Anti-inflammatory activity
下载PDF
STUDIES ON THE SYNTHESIS OF DIMETHYI,4-HYDROXY -4'-METHOXY-5,6,5',6'-BISMETHYLENEDIOXYBIPHENYL-2,2'-DICAPBOXYLATE——AN ESSENTIAL METABOLITE OF DDB
6
作者 Shu Li ZHAN Chun Zhen ZHANG Institute of Materia Medica,Chinese Academy of Medical Sciences Beijing 100050 《Chinese Chemical Letters》 SCIE CAS CSCD 1992年第1期29-32,共4页
This paper reports the total synthesis of dimethyl 4-hydroxy-4’-methoxy-5,6,5’,6’-bismethylenedioxybiphenyl-2,2’-dicarboxylate(Ⅱ). Various conditions for bromination were tried to find the best one for synthesis ... This paper reports the total synthesis of dimethyl 4-hydroxy-4’-methoxy-5,6,5’,6’-bismethylenedioxybiphenyl-2,2’-dicarboxylate(Ⅱ). Various conditions for bromination were tried to find the best one for synthesis of the key intermediate compd 6.After Lllmann condensation of 6 with 8 and hydrogenolysis, the title compd Ⅱ was obtained.It was proved to be identical with the isolated metabolite of DDB by spectral data. 展开更多
关键词 AN ESSENTIAL METABOLITE OF DDB BISMETHYLENEDIOXYBIPHENYL-2 2 DICAPBOXYLATE METHOXY-5 6 5 STUDIES ON THE SYNTHESIS OF DIMETHYI 4-hydroxy
下载PDF
Synthesis and Evaluation of 4-Hydroxy Quinolinone Derivatives as Antioxidants of Lubricating Grease
7
作者 Modather F. Hussein Mostafa A. Ismail Refaat A. El-Adly 《International Journal of Organic Chemistry》 CAS 2016年第4期207-219,共13页
3-(5-(2.4-dichlorophyenyl)-4.5-dihydro-1H-pyrazol-3-yl)-4hydroxy-1-methylquinolin(1H)-one, 5-((4-hydroxy-8-methyl-2-oxo-1.2-dihydroquinolin-3-yl)methylene)-1-phenyl-2-hioxodihydropyrimidine-4.6(1H.5H)-dione, and 1-but... 3-(5-(2.4-dichlorophyenyl)-4.5-dihydro-1H-pyrazol-3-yl)-4hydroxy-1-methylquinolin(1H)-one, 5-((4-hydroxy-8-methyl-2-oxo-1.2-dihydroquinolin-3-yl)methylene)-1-phenyl-2-hioxodihydropyrimidine-4.6(1H.5H)-dione, and 1-butyl-4-hydroxy-3-(5-styryl-4.5-dihydro-1H-pyrazol-3yl)quinolin-2(1H)-one were synthesized and characterized by spectroscopy analysis. These compounds are designated I, II and III, respectively. The antioxidants efficiency of the synthesized compounds in lubricating greases had been investigated using ASTM d-942 and ASTM d-664. The obtained data showed that the total acid number and oxygen pressure drop of these compounds in lubricating greases decrease in the order: Comp.III. < Comp.I. < Comp.II. The antioxidant efficiency of the prepared quinolinones derivatives was discussed. Acceptable correlations were obtained between the obtained oxidation inhibition and the calculated quantum chemical parameters. 展开更多
关键词 Lubricating Greases ANTIOXIDANTS 4-hydroxy Quinolinone Quantum Chemical Calculation
下载PDF
Facile Resolution of Racemic 4-Phenyl-2-hydroxy Butyrate via Enzymatic Esterification and Transesterification
8
作者 Jin wang Xu Zu yi Li 《Chinese Chemical Letters》 SCIE CAS CSCD 1991年第12期927-928,共2页
The optically active R-4-phenyl-2-hydroxy butyrates were prepared by esterification of the racemic acid or transesterification of the racemic ester catalyzed by lipase from Candida cyclindra (CCL) in organic media.
关键词 Res Facile Resolution of Racemic 4-Phenyl-2-hydroxy Butyrate via Enzymatic Esterification and Transesterification
下载PDF
液-质联用法测定乳腺癌患者体内他莫昔芬及其活性代谢物4-羟基三苯氧胺的含量 被引量:6
9
作者 孙颖 窦桂芳 +1 位作者 孟志云 李萍萍 《中国临床药理学杂志》 CAS CSCD 北大核心 2006年第4期299-302,共4页
目的建立测定他莫昔芬及其主要代谢产物4-羟基三苯氧胺血药浓度的液相色谱-质谱方(LC-MS)法,并测定其在乳腺癌患者的血药浓度.方法18例乳腺癌患者服用他莫昔芬后,其血浆样品经异丙醇-正己烷萃取后,用LC-MS法测定血浆中他莫昔芬及其活... 目的建立测定他莫昔芬及其主要代谢产物4-羟基三苯氧胺血药浓度的液相色谱-质谱方(LC-MS)法,并测定其在乳腺癌患者的血药浓度.方法18例乳腺癌患者服用他莫昔芬后,其血浆样品经异丙醇-正己烷萃取后,用LC-MS法测定血浆中他莫昔芬及其活性代谢物4-羟基三苯氧胺浓度.结果他莫昔芬、4-羟基三苯氧胺血药浓度分别在10~500,1~20ng·mL^-1内,线性关系良好;血清浓度分别为(211.62±81.46),(4.78±1.52)ng·mL^-1.结论此方法适于乳腺癌患者体内他莫昔芬浓度的监测. 展开更多
关键词 液相色谱-质谱法 他莫昔芬 4-羟基三苯氧胺 乳腺癌
下载PDF
CYP2D6基因多态性与他莫昔芬及4-羟基他莫昔芬血清浓度的相关性研究 被引量:5
10
作者 田超 杨义 李卉 《四川医学》 CAS 2014年第1期4-6,共3页
目的 探讨CYP2D6基因多态性与乳腺癌患者他莫昔芬(TAM)及其活性代谢产物4-羟基他莫昔芬(4-OH-TAM)血清浓度的相关性.方法 收集2008年1月~2010年10月期间200例服用TAM的乳腺癌患者的口腔粘膜及血清,采用Real-time RT-PC法检测CYP2D6... 目的 探讨CYP2D6基因多态性与乳腺癌患者他莫昔芬(TAM)及其活性代谢产物4-羟基他莫昔芬(4-OH-TAM)血清浓度的相关性.方法 收集2008年1月~2010年10月期间200例服用TAM的乳腺癌患者的口腔粘膜及血清,采用Real-time RT-PC法检测CYP2D6*10基因多态性,采用液相色谱-质谱方法 (LC-MS)测定患者体内TAM及其活性代谢物4-OH-TAM的的血清浓度.结果 200例乳腺癌中检测到CYP2D6*10/*10纯合子94例(47%),CYP2D6 wt/wt野生型48例(24%),CYP2D6 wt/*10杂合型58例(29%).CYP2D6 wt/wt野生型和wt/*10杂合型两组4-OH-TAM的血清浓度都明显高于*10/*10纯合型(P〈0.05),各基因型之间TAM血清浓度值差异无统计学意义(P〉0.05).结论 乳腺癌患者CYP2D6*10/*10基因型影响他莫昔芬的体内代谢过程,与疗效相关,服用TAM前均应推荐检测CYP2D6*10/*10基因型. 展开更多
关键词 乳腺癌 他莫昔芬 CYP2D6 4-羟基他莫昔芬
下载PDF
雌激素受体拮抗剂他莫昔芬和4-羟基他莫昔芬治疗非小细胞肺癌的实验研究 被引量:15
11
作者 朱晓莉 张祖贻 朱毅 《药学进展》 CAS 2002年第6期344-348,共5页
[目的 ]探讨雌激素受体拮抗剂在非小细胞肺癌治疗中的作用。 [方法 ]用逆转录多聚酶链式反应 (RT-PCR)测定肺腺癌细胞株 SPC- A- 1的雌激素受体 m RNA(ER- m RNA)表达 ,分别在去激素培养条件下观察不同浓度的他莫昔芬 (Tam)、4-羟基他... [目的 ]探讨雌激素受体拮抗剂在非小细胞肺癌治疗中的作用。 [方法 ]用逆转录多聚酶链式反应 (RT-PCR)测定肺腺癌细胞株 SPC- A- 1的雌激素受体 m RNA(ER- m RNA)表达 ,分别在去激素培养条件下观察不同浓度的他莫昔芬 (Tam)、4-羟基他莫昔芬 (OHTam)和雌二醇 (E2 )对其生长速度、细胞周期时相、ER- m RNA水平和细胞形态学的影响。 [结果 ] SPC- A- 1肺腺癌细胞株有 ER- m RNA表达 ,低浓度 E2 (1 0 -8mol/ L)可促进其生长 ,Tam(1 0 -6mol/ L )和 OHTam(1 0 -6mol/ L)可抑制 E2 (1 0 -8mol/ L )的生长刺激作用。去激素环境下细胞生长明显减慢 ,在无激素环境中亦能抑制细胞生长 ,抑制发生在 G0 / G1 期 ,并有细胞内质网扩张等结构改变 ,ER- m RNA表达水平下降。 [结论 ]肺腺癌 SPC- A- 1细胞株的生长具有雌激素依赖性 ,应用 ER拮抗剂 Tam和 OHTam能抑制其生长。肺癌细胞中 展开更多
关键词 非小细胞肺癌 NSCLC 雌激素受体拮抗剂 雌二醇 他莫昔芬 4-羟基他莫昔芬 逆转录多聚酶链式反应
下载PDF
HIF-1α调控4-羟基他莫昔芬对乳腺癌MCF-7细胞敏感性的研究 被引量:2
12
作者 陈宗跃 张璟钰 +4 位作者 张敏琴 樊双琴 沈祥春 陈妍 张玥 《安徽医科大学学报》 CAS 北大核心 2022年第6期938-943,共6页
目的该研究通过建立人乳腺癌4-羟基他莫昔芬(4-OHT)耐药细胞系(MCF-7/TR),探究低氧诱导因子1α(HIF-1α)对乳腺癌MCF-7细胞4-OHT耐药的影响。方法采用他莫昔芬的体内活性形式4-OHT建立乳腺癌耐药细胞MCF-7/TR。MTT实验检测4-OHT对乳腺... 目的该研究通过建立人乳腺癌4-羟基他莫昔芬(4-OHT)耐药细胞系(MCF-7/TR),探究低氧诱导因子1α(HIF-1α)对乳腺癌MCF-7细胞4-OHT耐药的影响。方法采用他莫昔芬的体内活性形式4-OHT建立乳腺癌耐药细胞MCF-7/TR。MTT实验检测4-OHT对乳腺癌细胞MCF-7、MCF-7/TR细胞活力的影响,并测定耐药指数(RI);Western blot检测MCF-7、MCF-7/TR细胞中HIF-1α蛋白的表达水平;采用MTT法和流式细胞术AV/PI双染法检测,HIF-1α抑制剂(LW6)或siRNA HIF-1α干预作用后4-OHT对MCF-7/TR细胞的影响以及HIF-1α稳定剂(FG-4592)处理后4-OHT对MCF-7细胞的影响。结果结果显示,MCF-7/TR耐药细胞株成功构建,其RI为(5.56±0.80);与MCF-7细胞相比,MCF-7/TR细胞中HIF-1α高表达,且4-OHT作用后MCF-7/TR细胞中HIF-1α的表达水平上调;给予LW6或沉默HIF-1α的表达后,HIF-1α的表达下调增强了4-OHT对MCF-7/TR细胞的抑制作用;给予FG-4592后,HIF-1α的表达上调可降低4-OHT对MCF-7细胞的抑制作用。结论HIF-1α在乳腺癌MCF-7细胞4-OHT耐药中发挥重要作用,靶向HIF-1α可能是增加乳腺癌细胞对他莫昔芬敏感性的有效途径。 展开更多
关键词 乳腺癌 耐药 4-羟基他莫昔芬 低氧诱导因子1Α
下载PDF
以甘油为碳源发酵高产反式-4-羟脯氨酸菌株的选育及营养优化
13
作者 王金霞 黄建华 +3 位作者 于林 张震宇 岳春 孙付保 《食品与发酵工业》 CAS CSCD 北大核心 2016年第7期40-47,共8页
以低品级甘油为碳源进行微生物发酵合成反式-4-羟脯氨酸(Trans-4-hydroxy proline,Hyp)的探索。从实验室构建的重组菌E.coli BL21(DE3)/p UC19-ptrp2-Hyp出发,通过易错PCR随机突变和常压室温等离子体复合诱变处理,利用单菌落琼脂块和氨... 以低品级甘油为碳源进行微生物发酵合成反式-4-羟脯氨酸(Trans-4-hydroxy proline,Hyp)的探索。从实验室构建的重组菌E.coli BL21(DE3)/p UC19-ptrp2-Hyp出发,通过易错PCR随机突变和常压室温等离子体复合诱变处理,利用单菌落琼脂块和氨基酸显色相结合高通量筛选出1株以甘油为唯一碳源的Hyp高产菌P71。与葡萄糖培养基相比,该菌株更适合在甘油上生长并转化L-脯氨酸合成Hyp,发酵20 h产Hyp高达1.20g/L,比生长在葡萄糖培养基上高70%以上;比其出发菌株在葡萄糖培养基上产量提高了1倍以上。通过培养基成分系统优化,发现胰蛋白胨、Fe SO4和L-脯氨酸是3大主要影响因素,最适加量分别为7.01 g/L、11.51 g/L和1.41 mmol/L;在该条件下突变菌株摇瓶发酵12 h产Hyp达1.61 g/L,比优化前提高了50%。 展开更多
关键词 低品级甘油 重组大肠杆菌 反式-4-羟脯氨酸(Traas-4-hydroxy—L-proline Hyp) 复合突变 营养优化
下载PDF
消乳散结胶囊对乳腺癌癌前病变大鼠乳腺组织CXCR4及VEGF表达的影响 被引量:1
14
作者 邓卫芳 裴晓华 《河南中医》 2020年第9期1360-1364,共5页
目的:观察消乳散结胶囊对乳腺癌癌前病变大鼠乳腺组织基质细胞衍生因子受体4(cxcchemokin receptor 4,CXCR4)、血管内皮生长因子(vascular endothelial growth factor,VEGF)基因及蛋白表达的干预作用。方法:将40只大鼠随机分为空白组、... 目的:观察消乳散结胶囊对乳腺癌癌前病变大鼠乳腺组织基质细胞衍生因子受体4(cxcchemokin receptor 4,CXCR4)、血管内皮生长因子(vascular endothelial growth factor,VEGF)基因及蛋白表达的干预作用。方法:将40只大鼠随机分为空白组、模型组、西药组和中药组,每组各10只。除空白组外,其余各组均用二甲基苯蒽(dimehylpheny lanthracene,DMBA)结合慢性不可预见应激行为制备乳腺癌癌前病变肝郁痰凝证模型。造模成功后,空白组及模型组大鼠给予蒸馏水10 mL·kg^-1灌胃;西药组大鼠给予枸橼酸他莫昔芬水溶液1.8 mg·kg^-1灌胃,中药组大鼠给予消乳散结胶囊水溶液0.324 g·kg^-1灌胃,连续灌胃30 d。HE染色观察乳腺组织病理变化,ELISA法检测血清孕酮(progesterone,P)、雌二醇(estradiol,E_2)变化情况,Real-time PCR及Western blot法检测各组大鼠VEGF、CXCR4 mRNA及蛋白表达水平。结果:西药组、模型组、中药组肿瘤发生率高于空白组,差异均有统计学意义(P<0.05);中药组肿瘤发生率高于模型组,差异具有统计学意义(P<0.05)。空白组、西药组和中药组E_2水平均低于模型组,差异有统计学意义(P<0.05)。各组P水平比较,差异无统计学意义(P>0.05)。模型组、西药组VEGF mRNA表达及蛋白水平低于空白组,差异有统计学意义(P<0.01),中药组与空白组比较,差异无统计学意义(P>0.05)。西药组、中药组VEGF、CXCR4 mRNA表达及蛋白水平均低于模型组,差异均有统计学意义(P<0.05)。结论:消乳散结胶囊可能是通过调整E_2分泌,并抑制VEGF及CXCR4基因表达,从而抑制新生血管生成实现控制大鼠乳腺癌癌前病变的作用。 展开更多
关键词 乳腺癌癌前病变 消乳散结胶囊 枸橼酸他莫昔芬 基质细胞衍生因子受体4 血管内皮生长因子 大鼠
下载PDF
披针新月蕨中的两个新黄烷苷 被引量:4
15
作者 赵钟祥 金晶 +2 位作者 阮金兰 蔡亚玲 祝晨蔯 《药学学报》 CAS CSCD 北大核心 2008年第4期392-395,共4页
为了研究披针新月蕨的化学成分,采用不同色谱方法进行分离纯化,从披针新月蕨地上部分的正丁醇萃取部位分离得到2个化合物,根据光谱数据和理化性质进行结构鉴定,分别鉴定为4-′hydroxy pneum atopterin B(I)和6″-O-acetyl triphyllin A(... 为了研究披针新月蕨的化学成分,采用不同色谱方法进行分离纯化,从披针新月蕨地上部分的正丁醇萃取部位分离得到2个化合物,根据光谱数据和理化性质进行结构鉴定,分别鉴定为4-′hydroxy pneum atopterin B(I)和6″-O-acetyl triphyllin A(II)。化合物I和II为新化合物。 展开更多
关键词 披针新月蕨 黄烷苷 4-hydroxy pneumatopterin B:6″-O-acetyl triphyllin A
下载PDF
中国人CYP3A5和CYP2D6基因多态性与他莫昔芬及其活性代谢物血药浓度的相关性 被引量:8
16
作者 张宇馨 李亚芬 +2 位作者 陈冰 张伟霞 蔡卫民 《中国药师》 CAS 2010年第9期1229-1232,共4页
目的:研究中国汉族人群CYP3A5和CYP2D6基因多态性与乳腺癌患者体内他莫昔芬及其活性代谢物4-羟基他莫昔芬血药浓度的相关性。方法:30例乳腺癌患者,应用PCR方法检测其CYP3A5和CYP2D6基因型,应用LC-MS/MS方法测定患者体内他莫昔芬及其活... 目的:研究中国汉族人群CYP3A5和CYP2D6基因多态性与乳腺癌患者体内他莫昔芬及其活性代谢物4-羟基他莫昔芬血药浓度的相关性。方法:30例乳腺癌患者,应用PCR方法检测其CYP3A5和CYP2D6基因型,应用LC-MS/MS方法测定患者体内他莫昔芬及其活性代谢物4-羟基他莫昔芬的含量,对试验数据进行统计分析。结果:CYP3A5基因型与乳腺癌患者体内他莫昔芬的浓度差异有统计学意义,比较发现*1/*1和*1/*3组的他莫昔芬的浓度值明显低于*3/*3组(P<0.01)。CYP2D6基因型与其活性代谢物4-羟基他莫昔芬的浓度差异有统计学意义;*1/*1和*1/*10两组4-羟基他莫昔芬的浓度值都明显高于*10/*10组(P<0.01),但*1/*1组和*1/*10组之间4-羟基他莫昔芬的浓度值差异无统计学意义(P>0.05)。结论:乳腺癌患者的CYP3A5和CYP2D6基因型影响他莫昔芬的体内代谢。 展开更多
关键词 CYP3A5 CYP2D6 基因多态性 乳腺癌 他莫昔芬 4-羟基他莫昔芬
下载PDF
应用他莫昔芬治疗的乳腺癌患者进行CYP2D6联合SULT1A1基因多态性检测2例 被引量:2
17
作者 张晓斌 石蕊 +1 位作者 赵可新 李岑 《河北医学》 CAS 2018年第7期1230-1232,共3页
乳腺癌是女性发病率最高的恶性肿瘤之一,在我国每年新发病例约为27万,且发病率逐年递增[1]。我国的女性乳腺癌患者雌激素受体(ER)的阳性率可达70%,这部分患者的辅助内分泌治疗通常首选他莫昔芬(Tamoxifen,TAM),早期乳腺癌临床试验协作组... 乳腺癌是女性发病率最高的恶性肿瘤之一,在我国每年新发病例约为27万,且发病率逐年递增[1]。我国的女性乳腺癌患者雌激素受体(ER)的阳性率可达70%,这部分患者的辅助内分泌治疗通常首选他莫昔芬(Tamoxifen,TAM),早期乳腺癌临床试验协作组(EBCTCG)的研究显示,初次确诊为乳腺癌的患者采用TAM进行内分泌的辅助治疗能够显著降低15年复发和死亡率[2]。受个体差异因素的影响,约有30~50%的乳腺癌患者采用TAM辅助治疗预后较差或治疗失败[3]。有研究发现,他莫昔芬能够被CYP2D6酶充分代谢,催化产生高活性代谢物4-羟基他莫昔芬和4-羟-N-去甲基他莫昔芬。CYP2D6慢代谢者体内活性代谢物的水平较低。 展开更多
关键词 4-羟基他莫昔芬 辅助内分泌治疗 CYP2D6 乳腺癌患者 基因多态性 tamoxifen 活性代谢物 检测
下载PDF
MICROBIAL TRANSFORMATION OF 19-HYDROXY-CHOLESTEROL ACETATE OR 19-HYDROXY-β-SITOSTEROL ACETATE TO △~4-19-HYDROXY ANDROST-3, 17-DIONE
18
作者 周维善 殷芝华 王敬一 《Chinese Science Bulletin》 SCIE EI CAS 1991年第16期1386-1387,共2页
The increasing medicinal importance of 19-norsteroids, particularly for oral contraceptives, has stimulated intensive research to continuously find more economic methods of either partial and total direct synthesis or... The increasing medicinal importance of 19-norsteroids, particularly for oral contraceptives, has stimulated intensive research to continuously find more economic methods of either partial and total direct synthesis or indirect synthesis via estrone of this class of compound. 展开更多
关键词 microbial transform ation 19-hydroxycholesterol ACETATE 19-hydroxy-β-sitosterol ACETATE △~4-19-hydroxy androst-3 17-dione.
原文传递
Palladium (0) Nanoparticles: A Novel and Reusable Catalyst for the Synthesis of Various Pyran Derivatives
19
作者 Mithu Saha Amarta Kumar Pal 《Advances in Nanoparticles》 2012年第3期61-70,共10页
A ligand free, Palladium nanoparticles catalyzed synthesis of pyran derivatives using C-H activated compound, malononitrile and aryl aldehyde via Knoevenagel condensation followed by Michael addition reaction using Pa... A ligand free, Palladium nanoparticles catalyzed synthesis of pyran derivatives using C-H activated compound, malononitrile and aryl aldehyde via Knoevenagel condensation followed by Michael addition reaction using Palladium nanoparticles as catalyst in one-pot is described herein. The advantages of this method lie in its simplicity, low catalyst loading, cost effectiveness and easy to handle. The Palladium Nanoparticles can be reused without loss of activity even after recycling four times. The palladium nanoparticles were characterized by powder X-ray diffraction (XRD), transmission electron microscopy (TEM). The present method also allows us to synthesize highly functionalized title compounds from simple and readily available inputs. 展开更多
关键词 PALLADIUM NANOPARTICLES MULTI-COMPONENT Reaction PYRAN Derivatives DIMEDONE 4-hydroxy COUMARIN Pyranazolone
下载PDF
LC-MS/MS法测定大鼠血浆中他莫昔芬与其活性代谢物4-羟基他莫昔芬的浓度及其药动学研究 被引量:1
20
作者 刘昌辉 黄小桃 +4 位作者 郑侠 李能 李颖仪 宓穗卿 王宁生 《中国药房》 CAS CSCD 2012年第21期1962-1964,共3页
目的:建立大鼠血浆中他莫昔芬与其活性代谢物4-羟基他莫昔芬浓度的测定方法,并研究其在大鼠体内的药动学。方法:取大鼠8只灌胃给予他莫昔芬10mg·kg-1,检测给药前和给药后48h内他莫昔芬和4-羟基他莫昔芬的血浆浓度,并计算其药动学... 目的:建立大鼠血浆中他莫昔芬与其活性代谢物4-羟基他莫昔芬浓度的测定方法,并研究其在大鼠体内的药动学。方法:取大鼠8只灌胃给予他莫昔芬10mg·kg-1,检测给药前和给药后48h内他莫昔芬和4-羟基他莫昔芬的血浆浓度,并计算其药动学参数。采用液相色谱-串联质谱法,以维拉帕米为内标,色谱柱为PhenomenexGeminiC18,流动相为甲醇-0·025%甲酸水溶液(梯度洗脱),流速为0·25mL·min-1,柱温为40℃;电喷雾正离子源,他莫昔芬、4-羟基他莫昔芬和维拉帕米的选择检测离子质荷比(m/z)分别为372·3→129·1、388·4→128·9、455·3→165·0。结果:他莫昔芬和4-羟基他莫昔芬检测浓度的线性范围分别为1~500(r=0·9998)、0·5~50(r=0·9995)ng·mL-1,最低检测限分别为0·05、0·1ng·mL-1;药动学参数分别为t1/2β:(8·9±0·5)、(8·6±0·7)h,cmax:(112·2±39·2)、(31·1±5·6)ng·mL-1,AUC0~48h:(1501·1±213·8)、(431·2±31·8)ng·h·mL-1。结论:本方法专属性强、灵敏度高、准确性好,可用于他莫昔芬和4-羟基他莫昔芬的血药浓度测定。他莫昔芬和4-羟基他莫昔芬在大鼠体内的药动学符合一室模型特征。 展开更多
关键词 他莫昔芬 4-羟基他莫昔芬 大鼠 液相色谱-串联质谱法 药动学
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部